Adam Koppel Insider Trading $CERE Cerevel Therapeutics Holdings, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Adam Koppel.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Adam Koppel. Adam Koppel is EVP, Strategy and Bus. Dev. in BIOGEN INC. ($IDPH) and SVP, Chief Strategy Officer in BIOGEN INC. ($IDPH) and Director in PTC THERAPEUTICS, INC. ($PTCT) and Director in Dicerna Pharmaceuticals Inc ($DRNA) and Director in TREVENA INC ($TRVN) and Director in Aptinyx Inc. ($APTX) and Director in Solid Biosciences Inc. ($SLDB) and Director in Cerevel Therapeutics Holdings, Inc. ($ARYB).

Adam Koppel in Cerevel Therapeutics Holdings, Inc.

Trading Symbol: CERE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Adam Koppel: Director
Holdings: 60,632,356 shares
Latest Transaction: Nov 12 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Adam Koppel in Cerevel Therapeutics Holdings, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, APTX, IDPH, CERE, DRNA, PTCT, SLDB, TRVN

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Nov 12 2020ARYBCerevel Therapeuti ...Koppel AdamDirectorBuyP10.30332,2933,422,61860,632,35660.3 M to 60.6 M (+0.55 %)

Page:   1